… non-small cell lung cancer, a type of lung cancer known for … outcomes for patients with KRAS-mutant cancers." Eric … and P30CA076292), the Moffitt Lung Cancer Center of Excellence and … mutant non–small cell lung cancer. Clinical Cancer Research. doi …

… non-small cell lung cancer, a type of lung cancer known for … outcomes for patients with KRAS-mutant cancers.” The new … and P30CA076292), the Moffitt Lung Cancer Center of Excellence and Revolution … -mutant non–small cell lung cancer Article Publication Date 21 …

… better outcomes for patients with KRAS-mutant cancers.” The promise of … lung cancer therapeuticsbiomarker for lung cancer treatmentcancer biomarker discoveryclinical implications of KRASG12CKRASG12C inhibitors in lung cancerMoffitt …

… -9805) for patients with KRAS G12D pancreatic ductal adenocarcinoma based … types. KRAS G12D makes up about 4% of lung cancer cases. … mutations that develop after KRAS G12D therapy, based on … several years ago, are other KRAS mutations. So, can combination …

… published in Clinical Lung Cancer.1 The copy … driver-positive when excluding KRAS mutations,” investigators wrote. … comparisons,” investigators wrote. “KRAS mutations (36.87% no … KRAS and MET copy-number gain in nonsmall cell lung cancer. Clin Lung Cancer …

… gain in non–small cell lung cancer (NSCLC) tumors, and … BRAF TKIs exist in lung cancer, and they’re approved … negative prognostic association. For KRAS, that association was present … KRAS and MET copy-number gain in nonsmall cell lung cancer. Clin Lung Cancer …

… activity in patients with KRAS G12D–mutated pancreatic … advanced solid tumors harboring KRAS G12D mutations. To … cancer, non–small cell lung cancer, sinonasal adenocarcinoma, melanoma of … inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma …

… in discovering novel drugs for lung cancer treatment. Leading the charge in … molecules targeting the cancer-linked KRAS protein, previously deemed undruggable. This …

… adenocarcinoma or non–small cell lung cancer (NSCLC) harboring NRG1 gene fusion … clinically relevant thresholds for MET, KRAS, and HER2 gene copy number … a subgroup of meaningfully HER2-, KRAS-, and MET-amplified cancers that …

… treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer … with extensive-stage small cell lung cancer whose disease has progressed on …